Thus, to characterize the implications of Annexin A2 binding to fibronectin, we examined whether Annexin A2 expression specifically affects the degradation of fibronectin by breast cancer cells, something that has not been directly investigated before. The gene discussed is ANXA2; the disease is breast cancer.